70 filings
Page 3 of 4
8-K
5so5bmcycbh5az
19 Jul 21
Regulation FD Disclosure
7:48am
8-K
5dxozx2zb6 2k
1 Jul 21
Submission of Matters to a Vote of Security Holders
9:04am
8-K
lls6 fgscr076t
18 May 21
Regulation FD Disclosure
4:03pm
8-K
nea31u3
17 Mar 21
Regulation FD Disclosure
7:50am
8-K
dltr s4ebntd
25 Feb 21
Regulation FD Disclosure
9:00am
8-K
0kyt2 j76krpz5
12 Feb 21
Entry into a Material Definitive Agreement
5:13pm
8-K
ce1sau 7a7jt8bwp
7 Jan 21
Regulation FD Disclosure
7:37am
8-K
1urtkxyqv15bug 86o
28 Dec 20
CNS Pharmaceuticals Announces Pricing of $10.0 Million Public Offering
4:30pm
8-K
4qwrut3 l22s3tjx
21 Dec 20
Other Events
9:01am
8-K
up2xq smi3
11 Dec 20
Regulation FD Disclosure
8:09am
8-K
oscemo4r et
12 Nov 20
Regulation FD Disclosure
12:00am
8-K
6hp632v
21 Sep 20
Entry into a Material Definitive Agreement
8:03am
8-K/A
siv3z
16 Sep 20
Regulation FD Disclosure
9:25am
8-K
tnq4g jvx
16 Sep 20
Regulation FD Disclosure
7:00am
8-K
hxosou71ryboe6rc7yq
4 Sep 20
Amendment to Employment Agreement
4:30pm
8-K
cmi0xr7a8cwpt2pxi
25 Jun 20
Regulation FD Disclosure
8:44am
8-K
n69ccbc1nk8q0jyx rg4
11 Jun 20
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
4:30pm
8-K
o1hdac oqs
9 Jun 20
Submission of Matters to a Vote of Security Holders
5:20pm
8-K
tf0j9vpc2mm6m8wzk
28 May 20
Other Events
7:00am
8-K
6hmv 609h4h
27 May 20
CNS Provides Update on Development
5:15pm